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Autosomal dominant polycystic kidney disease (ADPKD) is
a common hereditary condition that may be diagnosed
in utero. Our goal was to evaluate symptoms of ADPKD in
children, including left ventricular mass index (LVMI), renal
volume, renal function and microalbuminuria in relation to
systolic and diastolic blood pressure. Eighty-five children
were stratified by blood pressure into three cohorts:
hypertensive (95th percentile and over), borderline
hypertensive (75–95th percentile) and normotensive (75th
percentile and below). There were no differences in gender,
age, height, renal function, or microalbuminuria between the
groups. Both the hypertensive and borderline hypertensive
children had a significantly higher LVMI than normotensive
children, with no significant difference between hypertensive
and borderline hypertensive groups. There was a significant
correlation between renal volume and both systolic and
diastolic blood pressures in all subjects. Renal volume in
hypertensive children was significantly larger than in the
borderline hypertensive group, with no significant difference
between normotensive and borderline hypertensive groups.
These findings show that an increase in LVMI may be
detected earlier than an increase in renal volume in children
with ADPKD and borderline hypertension, suggesting that
close monitoring of cardiac status is indicated in these
children.
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Autosomal dominant polycystic kidney disease (ADPKD) is
the most common life-threatening hereditary renal disease,
affecting 1 in 400 to 1 in 1000 individuals in the United
States.1 ADPKD had previously been known as Adult
Polycystic Kidney Disease. It is now clear, however, that
affected children and adolescents exhibit several features of
ADPKD. Moreover, ADPKD has even been diagnosed in
utero.2,3
In most diseases, early intervention is more likely to alter
the clinical course as compared to later intervention. Thus, it
is important to identify the clinical characteristics of ADPKD
at an early age. Previous studies have shown that hyperten-
sion is associated with faster progression to end-stage renal
disease4 and increased cardiovascular morbidity and mortal-
ity in adults with ADPKD.5 The present study was therefore
undertaken to evaluate the clinical manifestations of ADPKD
in children and adolescents, including left ventricular mass
index (LVMI), renal volume and function, and microalbu-
minuria in relation to systolic and diastolic blood pressure
(BP) adjusted for sex, age, and height. A total of 85 children
with a mean age of 12.8 years were analyzed according to
three levels of BP, namely hypertension (HBP; greater than
the 95th percentile for sex, age, and height), borderline
hypertension (BBP; 75–95th percentile), and normotension
(NBP; less than the 75th percentile).
RESULTS
Demographics
A total of 85 children participated in this study. The
characteristics of these subjects are shown in Table 1
according to the three categories of BP including NBP, BBP,
and HBP. There were no differences in sex, age, height, or
renal function between the groups. Urinary microalbumin
excretion was not significantly different between the groups.
Correlation between LVMI and blood pressure
A significant correlation between LVMI and systolic BP
(r¼ 0.45, Po0.0001) for all 85 patients was observed
(Figure 1a). Similarly, LVMI correlated significantly with
diastolic BP (r¼ 0.29, Po0.007; Figure 1b). Multiple linear
regression with age, height, and sex as covariates confirmed a
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significant predictive value of systolic BP on the log of LVMI
(P¼ 0.0004), whereas diastolic BP was not significant after
accounting for age, height, and sex (P¼ 0.14).
Left ventricular mass index by blood pressure group
The HBP children had significantly higher LVMI than the NBP
group (Figure 2). The LVMI in the BBP group was significantly
greater than in the NBP children. There was no significant
difference in LVMI between the BBP and HBP groups.
Correlation between renal volume and blood pressure
There was a highly significant correlation between the log of
renal volume and systolic BP (r¼ 0.70, Po0.0001) for all 85
patients (Figure 3a). A similar correlation also occurred
between diastolic BP and renal volume (r¼ 0.52, Po0.0001;
Figure 3b). Multiple linear regression with age, height, and
sex as covariates confirmed a significant predictive value of
systolic BP on the log of renal volume (P¼ 0.0002), whereas
diastolic BP was not significant after accounting for age,
height, and sex (P¼ 0.2).
Renal volume by blood pressure group
Kidney volumes were measured by ultrasonography in the
three BP groups (Figure 4). The renal volumes in the HBP
children were significantly larger than the renal volumes in
the BBP and NBP groups. There was no significant difference
in renal volumes between the NBP and BBP groups.
DISCUSSION
The purpose of the current study was to relate level of systemic
BP to clinical manifestations including LVMI and renal volume
in children and young adults with ADPKD. Within this study,
the demographics including age, sex, and height were
comparable between the three BP groups; this is important
due to the normal effects of growth on BP in children. Analysis
of all 85 children demonstrated a highly significant correlation
between both systolic and diastolic BP and LVMI. It was not
surprising that the group with hypertension demonstrated a
significant elevation in LVMI. Of particular importance,
Table 1 | The characteristics of normotensive (NBP), borderline hypertensive (BBP), and hypertensive (HBP) subjects
Parameter NBP (N=30) BBP (N=27) HBP (N=28) P-value for ANOVA
Male/female 13/17 15/12 17/11 NS
Age (years) 12.0±0.8 11.8±0.8 13.6±0.8 NS
Height (cm) 151±5 151±5 160±4 NS
Serum creatinine (mg/100 ml) 0.66 (0.57–0.70) 0.69 (0.62–0.77) 0.74 (0.68–0.81) NS
24-h creatinine clearance (ml/min/1.73 m2) 135 (127–145) 127 (117–138) 130 (120–141) NS
UMA (mg/day) 31 (19–51) 22 (14–35) 23 (16–33) NS
SBP (mm Hg) 109±2 119±2 130±3 o0.0001
DBP (mm Hg) 64±1 68±1 72±2 0.0005
DBP, diastolic blood pressure; NS, not significant; SBP, systolic blood pressure; UMA, urine microalbumin excretion.
Note. SBP: NBP vs BBP (P=0.0122), NBP vs HBP (Po0.0001), BBP vs HBP (P=0.0022); DBP: NBP vs BBP (P=NS), NBP vs HBP (P=0.0003), BBP vs HBP (P=NS). Data presented as
mean±s.e. or geometric mean (95% CI).
a
3
3.5
4
4.5
5
75 100 125 150 175
SBP (mm Hg)
Ln
 [L
VM
I] (
g/m
2 )
Borderline
Hypertensive
Normotensive
b
3
3.5
4
4.5
5
50 60 70 80 90 100
DBP (mm Hg)
Ln
 
[LV
M
I] (
g/m
2 )
Borderline
Hypertensive
Normotensive
r = 0.45 
P < 0.0001 
r = 0.29 
P < 0.007 
Figure 1 | Correlation between blood pressure and left
ventricular mass index (LVMI). There was a significant
correlation between mean systolic blood pressure (SBP) and
(LVMI) (a) as well as between mean diastolic blood pressure (DBP)
and LVMI (b) in all 85 subjects.
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Figure 2 | Left ventricular mass index (LVMI) was significantly
increased in hypertensive (HBP) as compared to borderline
hypertensive (BBP) and normotensive (NBP) children with
ADPKD. BBP children demonstrated significantly higher LVMI as
compared to NBP children with ADPKD. Data presented as
geometric mean with 95% confidence intervals (CI), adjusted for
age, sex, and height.
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however, was the finding that among ADPKD children with
normal BP, a significant increase in LVMI was present in those
with BP within the upper quartile of the normal range as
compared to those with lower BP. This elevation was detected
before any significant increase in renal volume, suggesting an
early and important cardiovascular effect of high normal BP
within this population.
We also observed a highly significant association between
both systolic and diastolic BP and renal volume. This is quite
interesting from several viewpoints. Renal volumes have
previously been shown to be larger in hypertensive versus
normotensive adults6,7 and children7–10 with ADPKD. The
present results support these observations. It has been
suggested that renal cyst expansion with attenuation of the
renal vasculature may be an important factor in the
generation of hypertension in adults with ADPKD.11–13 In
contrast, despite a significant difference in BP between
normotensive and borderline hypertensive children, there
was no detectable difference in renal volume between these
two groups. There are at least two potential explanations for
these findings. First, it may be that alternative factors are
important in the generation of BP in children with ADPKD.
Alternatively, it may be that ultrasonography is not sensitive
enough to detect differences in renal volume between
normotensive and borderline hypertensive children. Recent
studies in adults suggest that magnetic resonance imaging
provides a reliable assessment of renal structural disease in
ADPKD which is superior to that obtained by ultrasound;14
however, we note that in subsequent follow-up in this cohort
we were able to demonstrate significant interval change in
renal volume within 1 year with repeated ultrasound
assessment (unpublished results). Thus we believe our
findings to be clinically important.
Although microalbuminuria has been associated with
hypertension, increased renal volume, and left ventricular
mass (LVM) in adults with ADPKD,15–17 we found no similar
association in children with ADPKD.
With advances in renal replacement therapy, cardio-
vascular disease is now the primary cause of death in adults
with ADPKD.5 Thus, the observation that ADPKD children
with borderline hypertension had significantly greater LVMI
than the normotensive subjects would suggest that any
cardiac intervention in ADPKD children should not wait
until hypertension is established. A prospective randomized
study in hypertensive ADPKD patients with left ventricular
hypertrophy demonstrated that treatment with angiotensin
converting enzyme inhibitor reversed increased LVM in
association with aggressive BP control.18 Early treatment of
BP, for example, angiotensin converting enzyme inhibition,
may be indicated in children with ADPKD and borderline
hypertension.
MATERIALS AND METHODS
This study was supported by the National Institutes of Health and
was conducted at the Clinical Translational Research Center at The
Children’s Hospital in Denver, Colorado. Subjects were recruited
nationally from our ongoing studies of ADPKD, from physician
referrals, and from family responses to preliminary information
from the PKD Research Foundation. The research protocol was
reviewed and approved by the Colorado Multiple Institutional
Review Board. Informed consent/assent was obtained from all
subjects upon enrollment.
Inclusion criteria included children and adolescents (aged 4–21
years) with ADPKD and normal renal function. Patients were
considered to have ADPKD when radiographic imaging demon-
strated at least one renal cyst in the setting of a family history of
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Figure 3 | Correlation between blood pressure and renal
volume. There was a significant correlation between mean
systolic blood pressure (SBP) and renal volume (a) as well as
between mean diastolic blood pressure (DBP) and renal volume
(b) in all 85 subjects.
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Figure 4 | Renal volume was markedly increased in
hypertensive (HBP) as compared to borderline hypertensive
(BBP) and normotensive (NBP) children with ADPKD. Data
presented as geometric mean with 95% confidence intervals (CI),
adjusted for age, sex, and height.
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ADPKD or when multiple cysts were present and were clinically
consistent with a new diagnosis of ADPKD. Creatinine clearance was
estimated from the patient’s height and serum creatinine concen-
tration obtained within 6 months before enrollment using the
Schwartz formula.19 Blood pressure norms were determined based
on the subject’s sex, height, and age according to guidelines set forth
by the National High Blood Pressure Education Program.20–22 HBP
was defined as systolic and/or diastolic BP greater than the 95th
percentile for sex, age, and height on three or more measurements.
BBP was defined as systolic and/or diastolic BP between the 75th
and the 95th percentile for sex, age, and height on three or more
measurements. NBP was defined as systolic and/or diastolic BP less
than the 75th percentile for sex, age, and height on three or more
measurements. If a subject was already receiving antihypertensive
medication, hypertension was documented by reviewing records or
by close monitoring during a 1-week washout period. During this
washout period, medications were held as deemed clinically safe by
the principal investigators with BP assessed within 2 days of
stopping antihypertensive medication. Once hypertension was
documented, the subject’s usual antihypertensive regimen was
resumed. For the vast majority of subjects, hypertension could be
documented from previous records.
Once eligibility was confirmed, each subject was seen for a 2-day
visit at the Pediatric Clinical Translational Research Center at The
Children’s Hospital in Denver. All subjects underwent a detailed
history and physical examination. Blood was drawn for routine
serum chemistries and complete blood count. A routine urinalysis
was obtained. Two 24-h urine collections were obtained for
assessment of creatinine clearance and microalbumin excretion.
Abdominal ultrasound and echocardiography were performed as
described below.
On the first day of the visit, the dominant arm for BP
measurement was determined after 5 min of quiet sitting, and all
subsequent BP measurements were taken in the dominant arm with
a cuff appropriate for the size of the subject’s arm after 5 min of
quiet sitting. A total of 12 sitting BP measurements were obtained
during the study period using a programmable oscillometric BP
monitor (Dinamap 1846 SX; Critikon).
Standard two-dimensional and Doppler echocardiogram
was performed with the patient in a supine position using an
Accuson 128 XP/5 ultrasound. Neither the echocardiographer nor
the cardiologist reading the echocardiogram was aware of the
subject’s BP status. LVM was determined by the formula:
LVM¼ 0.80 (1.04 (LVDdþ PWTþ IVSd)3(LVDd)3)þ 0.6, where
LVDd¼ left ventricular diameter in diastole, PWT¼ posterior wall
thickness in diastole, and IVSd¼ ventricular septal thickness in
diastole.23 LVM was then corrected by body surface area and
reported as LVMI corrected for body surface area in g/m2.
Renal volumes were measured by performing standard abdom-
inal ultrasonography. Neither the ultrasound technician nor the
radiologist was aware of the subject’s BP status. Volumes were
calculated as the volume of a modified ellipse. Cyst number was
recorded as the actual number when less than 15 or as greater than
15 cysts per kidney.
Statistical analysis
Statistical analysis was performed using SAS 9.1. Outcome variables
were analyzed for the distributional assumption of normality.
Unadjusted baseline characteristics were compared between groups
using the ANCOVA. Natural log transformations were applied to
renal volume, LVM, and microalbumin excretion. ANCOVA was
used to compare groups after adjusting for age, height, and sex.
These data were reported as geometric mean and 95% confidence
intervals, adjusted for age, sex, and height. The Tukey–Kramer
P-value adjustment was used to determine which groups differed.
Pearson correlations and multiple linear regression were used to
show the relationships among variables in the population.
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